NASDAQ:BTMD biote (BTMD) Stock Price, News & Analysis $2.91 -0.07 (-2.35%) Closing price 10/6/2025 04:00 PM EasternExtended Trading$2.87 -0.04 (-1.37%) As of 10/6/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About biote Stock (NASDAQ:BTMD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get biote alerts:Sign Up Key Stats Today's Range$2.88▼$3.0050-Day Range$2.82▼$4.5552-Week Range$2.76▼$6.98Volume150,547 shsAverage Volume124,439 shsMarket Capitalization$143.87 millionP/E Ratio3.23Dividend YieldN/APrice Target$6.00Consensus RatingHold Company Overview biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas. Read More biote Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks44th Percentile Overall ScoreBTMD MarketRank™: biote scored higher than 44% of companies evaluated by MarketBeat, and ranked 653rd out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus Ratingbiote has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Upside Potentialbiote has a consensus price target of $6.00, representing about 106.2% upside from its current price of $2.91.Amount of Analyst Coveragebiote has only been the subject of 2 research reports in the past 90 days.Read more about biote's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth-28.00% Earnings GrowthEarnings for biote are expected to decrease by -28.00% in the coming year, from $0.75 to $0.54 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of biote is 3.23, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 234.36.Price to Earnings Ratio vs. SectorThe P/E ratio of biote is 3.23, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.53.Read more about biote's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted2.79% of the float of biote has been sold short.Short Interest Ratio / Days to Coverbiote has a short interest ratio ("days to cover") of 5.4.Change versus previous monthShort interest in biote has recently increased by 7.15%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend Yieldbiote does not currently pay a dividend.Dividend Growthbiote does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.79% of the float of biote has been sold short.Short Interest Ratio / Days to Coverbiote has a short interest ratio ("days to cover") of 5.4.Change versus previous monthShort interest in biote has recently increased by 7.15%, indicating that investor sentiment is decreasing significantly. News and Social Media0.6 / 5News SentimentN/A Search Interest7 people have searched for BTMD on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added biote to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, biote insiders have not sold or bought any company stock.Percentage Held by Insiders24.00% of the stock of biote is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 21.68% of the stock of biote is held by institutions.Read more about biote's insider trading history. Receive BTMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for biote and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BTMD Stock News HeadlinesRestructuring At Biote Will Drive Greater Growth And ProfitabilitySeptember 10, 2025 | seekingalpha.comInsider Stock Buying Reaches US$1.01m On bioteAugust 27, 2025 | finance.yahoo.comBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positioned at the absolute center of this incoming capital flood— a project so fundamentally essential to the crypto ecosystem that institutional investors simply cannot ignore it. | Crypto 101 Media (Ad)biote Corp. (BTMD) - Yahoo FinanceAugust 12, 2025 | finance.yahoo.combiote Corp. (NASDAQ:BTMD) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | msn.comB. Riley Securities Downgrades biote (BTMD)August 8, 2025 | msn.combiote Corp. (BTMD) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comBiote Reports Second Quarter 2025 Financial ResultsAugust 6, 2025 | businesswire.comSee More Headlines BTMD Stock Analysis - Frequently Asked Questions How have BTMD shares performed this year? biote's stock was trading at $6.18 at the start of the year. Since then, BTMD stock has decreased by 52.9% and is now trading at $2.91. How were biote's earnings last quarter? biote Corp. (NASDAQ:BTMD) announced its quarterly earnings data on Wednesday, August, 6th. The company reported $0.10 EPS for the quarter, beating analysts' consensus estimates of $0.06 by $0.04. The company earned $48.86 million during the quarter, compared to analyst estimates of $49.52 million. biote had a net margin of 15.73% and a negative trailing twelve-month return on equity of 21.00%. Read the conference call transcript. How do I buy shares of biote? Shares of BTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of biote own? Based on aggregate information from My MarketBeat watchlists, some other companies that biote investors own include Meta Platforms (META), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Visa (V) and Netflix (NFLX). Company Calendar Last Earnings8/06/2025Today10/06/2025Next Earnings (Estimated)11/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:BTMD CIK1819253 Webbiote.com Phone844-604-1246Fax212-616-9601Employees194Year FoundedN/APrice Target and Rating Average Price Target for biote$6.00 High Price Target$8.00 Low Price Target$4.00 Potential Upside/Downside+106.2%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$0.90 Trailing P/E Ratio3.23 Forward P/E Ratio3.88 P/E GrowthN/ANet Income$3.16 million Net Margins15.73% Pretax Margin19.17% Return on Equity-21.00% Return on Assets18.26% Debt Debt-to-Equity RatioN/A Current Ratio0.98 Quick Ratio0.74 Sales & Book Value Annual Sales$199.07 million Price / Sales0.72 Cash Flow$0.75 per share Price / Cash Flow3.89 Book Value($2.78) per share Price / Book-1.05Miscellaneous Outstanding Shares49,439,000Free Float37,574,000Market Cap$143.87 million OptionableNot Optionable Beta1.16 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:BTMD) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding biote Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share biote With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.